Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Kamada Ltd. (KMDA : NSDQ)
 
 • Company Description   
Kamada Ltd. is a biopharmaceutical company. It develops, produces and markets therapeutics based on chromatographic purification technology. The company offers bio-therapeutics for specialty proteins, specific immunoglobulins and other prescription medicines. Kamada Ltd. is headquartered in Ness Ziona, Israel.

Number of Employees: 357

 
 • Price / Volume Information   
Yesterday's Closing Price: $4.75 Daily Weekly Monthly
20 Day Moving Average: 13,303 shares
Shares Outstanding: (millions)
Market Capitalization: $ (millions)
Beta: 0.99
52 Week High: $6.96
52 Week Low: $4.48
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -14.41% -6.22%
12 Week -19.35% -12.50%
Year To Date -27.81% -14.16%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2 HOLTZMAN ST. SCIENCE PARK
-
REHOVOT,L3 7670402
ISR
ph: 972-8940-6472
fax: 972-8940-6473
ir@kamada.com http://www.kamada.com
 
 • General Corporate Information   
Officers
Amir London - Chief Executive Officer
Lilach Asher Topilsky - Chairman of the Board
Eran Nir - Chief Operating Officer
Chaime Orlev - Chief Financial Officer
Amiram Boehm - Director

Peer Information
Kamada Ltd. (CORR.)
Kamada Ltd. (RSPI)
Kamada Ltd. (CGXP)
Kamada Ltd. (BGEN)
Kamada Ltd. (GTBP)
Kamada Ltd. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: M6240T109
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 12/01/21
Next Expected EPS Date: 05/17/22
Share - Related Items
Shares Outstanding:
Most Recent Split Date: (:1)
Beta: 0.99
Market Capitalization: $ (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.03 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.14 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 05/17/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 33.93
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.20
Price/Cash Flow: 44.25
Price / Sales: -
EPS Growth
vs. Year Ago Period: -350.00%
vs. Previous Quarter: -400.00%
Sales Growth
vs. Year Ago Period: -0.23%
vs. Previous Quarter: 36.62%
ROE
03/31/22 - -
12/31/21 - -0.91
09/30/21 - 2.44
ROA
03/31/22 - -
12/31/21 - -0.68
09/30/21 - 2.06
Current Ratio
03/31/22 - -
12/31/21 - 2.41
09/30/21 - 6.73
Quick Ratio
03/31/22 - -
12/31/21 - 1.16
09/30/21 - 4.92
Operating Margin
03/31/22 - -
12/31/21 - -1.59
09/30/21 - 4.25
Net Margin
03/31/22 - -
12/31/21 - -2.15
09/30/21 - 4.25
Pre-Tax Margin
03/31/22 - -
12/31/21 - -1.82
09/30/21 - 4.52
Book Value
03/31/22 - -
12/31/21 - 3.97
09/30/21 - 4.08
Inventory Turnover
03/31/22 - -
12/31/21 - 1.46
09/30/21 - 1.59
Debt-to-Equity
03/31/22 - -
12/31/21 - 0.10
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - -
12/31/21 - 8.96
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©